Ildong Holdings Co Ltd
KRX:000230
Relative Value
The Relative Value of one Ildong Holdings Co Ltd stock under the Base Case scenario is hidden KRW. Compared to the current market price of 11 890 KRW, Ildong Holdings Co Ltd is hidden .
Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.
Multiples Across Competitors
Competitors Multiples
Ildong Holdings Co Ltd Competitors
| Market Cap | P/S | P/E | EV/EBITDA | EV/EBIT | ||||
|---|---|---|---|---|---|---|---|---|
| KR |
I
|
Ildong Holdings Co Ltd
KRX:000230
|
134.3B KRW | 0.2 | 2 | 3.4 | 11.2 | |
| US |
|
Eli Lilly and Co
NYSE:LLY
|
965.7B USD | 14.8 | 46.8 | 31.5 | 33.6 | |
| US |
|
Johnson & Johnson
NYSE:JNJ
|
594B USD | 6.3 | 22.2 | 15.4 | 18.9 | |
| CH |
|
Roche Holding AG
SIX:ROG
|
291.5B CHF | 4.8 | 31.2 | 13.1 | 15.3 | |
| UK |
|
AstraZeneca PLC
LSE:AZN
|
236.4B GBP | 5.5 | 31.7 | 17.5 | 24.6 | |
| CH |
|
Novartis AG
SIX:NOVN
|
242.5B CHF | 5.6 | 22.4 | 13.8 | 17.7 | |
| US |
|
Merck & Co Inc
NYSE:MRK
|
303.7B USD | 4.7 | 16.6 | 10.4 | 12.2 | |
| IE |
E
|
Endo International PLC
LSE:0Y5F
|
218B USD | 94 | -74.6 | 333.1 | 835.4 | |
| DK |
|
Novo Nordisk A/S
CSE:NOVO B
|
1.4T DKK | 4.4 | 13.4 | 9.8 | 11.5 | |
| US |
|
Pfizer Inc
NYSE:PFE
|
152.2B USD | 2.4 | 19.6 | 7.3 | 9.8 | |
| UK |
|
GSK plc
XETRA:GS71
|
105.9B EUR | 2.8 | 15.8 | 8 | 11.3 |